GNRSQ (The Greenrose Holding Co) EBIT: $-36.18 Mil (TTM As of Sep. 2022)


What is The Greenrose Holding Co EBIT?

The Greenrose Holding Co GNRSQ -99.00% EBIT is $-36.18 Mil as of Sep. 2022.

The Greenrose Holding Co's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2022 was $-25.38 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2022 was $-36.18 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. The Greenrose Holding Co's annualized ROC % for the quarter that ended in Sep. 2022 was -7.98%. The Greenrose Holding Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -389.18%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

The Greenrose Holding Co  (OTCPK:GNRSQ) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

The Greenrose Holding Co's annualized ROC % for the quarter that ended in Sep. 2022 is calculated as:

ROC % (Q: Sep. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2022 ) + Invested Capital (Q: Sep. 2022 ))/ count )
=-23.996 * ( 1 - 0% )/( (308.411 + 292.676)/ 2 )
=-23.996/300.5435
=-7.98 %

where

Invested Capital(Q: Jun. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=216.36 - 14.141 - ( 1.614 - max(0, 124.563 - 18.371+1.614))
=308.411

Invested Capital(Q: Sep. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=175.766 - 18.728 - ( 0.962 - max(0, 151.063 - 15.425+0.962))
=292.676

Note: The Operating Income data used here is four times the quarterly (Sep. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

The Greenrose Holding Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2022 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2022  Q: Sep. 2022
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-101.504/( ( (25.215 + max(2.277, 0)) + (24.671 + max(-4.283, 0)) )/ 2 )
=-101.504/( ( 27.492 + 24.671 )/ 2 )
=-101.504/26.0815
=-389.18 %

where Working Capital is:

Working Capital(Q: Jun. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.604 + 11.121 + 3.032) - (14.141 + 0.171 + 0.16799999999999)
=2.277

Working Capital(Q: Sep. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.954 + 11.878 + 0.631) - (18.728 + 0.018 + -2.8421709430404E-14)
=-4.283

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

The Greenrose Holding Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2022 )
=-36.184/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Greenrose Holding Co EBIT Related Terms

The Greenrose Holding Co EBIT Historical Data

* Premium members only.

The historical data trend for The Greenrose Holding Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Greenrose Holding Co EBIT Chart

The Greenrose Holding Co Annual Data
Trend Dec19 Dec20 Dec21
EBIT
0.00 15.68 0.00

The Greenrose Holding Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.17 0.00 -7.78 -3.03 -25.38

GNRSQ vs STLY, BLMS, WECT: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, The Greenrose Holding Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Greenrose Holding Co EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Greenrose Holding Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where The Greenrose Holding Co's EV-to-EBIT falls into.


The Greenrose Holding Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-36.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-36.18 Mil mean?
The Greenrose Holding Co (GNRSQ) has a EBIT of $-36.18 Mil as of Sep. 2022. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on The Greenrose Holding Co.
Is The Greenrose Holding Co's EBIT too high?
The Greenrose Holding Co's current EBIT is $-36.18 Mil.
How does The Greenrose Holding Co's EBIT compare to STLY and BLMS?
The Greenrose Holding Co's EBIT of $-36.18 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on The Greenrose Holding Co. The Greenrose Holding Co's current EBIT is $-36.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Greenrose Holding Co stock overvalued right now?
The Greenrose Holding Co (GNRSQ) has a current EBIT of $-36.18 Mil. The current EBIT is $-36.18 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For The Greenrose Holding Co (GNRSQ), the current EBIT is $-36.18 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Greenrose Holding Co Business Description

Other Exchanges GNRUQ:USA
Address 111 Broadway, Amityville, NY, USA, 11701
The Greenrose Holding Co is engaged in the manufacture and processing of cannabis in the adult-use and medical cannabis marketplace in Connecticut and Arizona.